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Introduction
Primary gastric lymphoma (PGL) comprises only a
minority of all gastric malignancies. The description of
MALT lymphoma and the “discovery” of Helicobacter
pylori in 1983 are landmarks in the history of gastric
lymphoma.1,2 In 1991, the relationship between 
H. pylori and gastric malignancies, both carcinoma
and lymphoma, was described for the first time.3,4
PGL is defined clinically as a dominant lesion within
the stomach.5 In the recently formalized WHO classi-
fication, gastric lymphoma is considered as the “dis-
ease entity” of marginal zone lymphoma, MALT-type
with a characteristic morphologic spectrum, immuno-
logic marker pattern and discriminative chromosomal
aberrations.6 The new insights in the role of chronic
H. pylori infection in the pathogenesis of gastric MALT
lymphoma have resulted in a disease-adapted therapy
with the substitution of traditional lymphoma thera-
pies, such as surgery, radiotherapy and chemotherapy,
with simple H. pylori eradication using antibiotics.
However, rates of about 7–15% H. pylori-negative gas-
tric MALT lymphoma patients have been reported.7–9
In those patients, H. pylori eradication therapy seems
to be irrelevant, and other therapeutic modalities are
required.
We present a case of gastric MALT lymphoma in
an H. pylori-negative patient, in whom partial gastric
resection was performed. We review the literature and
discuss the possible therapeutic options.
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Helicobacter pylori-negative primary mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach—a primary 
gastric lymphoma (PGL)—is not very common. Herein, we report a 77-year-old man with the chief complaint of intermit-
tent epigastric pain. Initial upper gastrointestinal (UGI) endoscopy showed multiple irregular ulcers (GUs) over the
antrum with poor distention of the stomach, and gastric adenocarcinoma (Borrmann type IV, linitis plastica) was sus-
pected. But the biopsy specimens of the GUs showed chronic inflammation without malignant change or H. pylori infec-
tion. Nevertheless, delayed healing of the GUs, specific endoscopic findings and enlarged paragastric lymph nodes on
computed tomography of the abdomen alerted us to the possibility of PGL. After repeat UGI endoscopies, the patient was
finally diagnosed with extranodal B-cell PGL. The patient received radical subtotal gastrectomy and Billroth II operation; the
surgical margins were free of tumor cells. The patient was followed up in the outpatient department for 20 months, and
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Case Report
This patient was a 77-year-old man with a history of
bleeding gastric ulcers in the past 1 year. In March
2005, he visited our outpatient department (OPD)
due to intermittent epigastralgia, postprandial fullness
and poor digestion for 2 months. Upper gastrointesti-
nal (UGI) endoscopy revealed many irregular ulcers
(0.9–1.2 cm in size) with erosive and hard surrounding
mucosa over the antrum. Due to its wide extension and
nodular appearance associated with the poor distention
of the stomach, Bormann type IV gastric cancer (lini-
tis plastica) was suspected. However, the pathologic
findings from the biopsy specimens of the ulcers only
showed intestinal metaplasia without H. pylori infec-
tion or malignancy. Abdominal sonography done at the
same time showed mild fatty liver and right renal cyst.
The 2nd UGI endoscopy done in April showed a sub-
mucosal tumor over the anterior wall, lesser curvature
side (LCS) of the antrum and extension to the LCS 
of the low body with several irregular nonbleeding
ulcers. However, the pathologic examinations revealed
the same results as obtained in March. However, the
3rd UGI endoscopy done in August, after 3 months
of proton pump inhibitor treatment, showed lack of
ulcers healing or regression of the submucosal tumor.
Thus, malignancy was still highly suspected, but the
pathologic findings of the biopsy specimen only showed
chronic inflammation and intestinal metaplasia with-
out H. pylori infection. However, abdominal computed
tomography (CT) showed irregular eccentric nodular
wall thickening over the LCS extending from the lower
body to the prepyloric region. Meanwhile, several para-
gastric lymph nodes (LNs, <0.5cm) over the left gastric
wall were also suspected by abdominal CT.
Due to the bizarre pattern of the mass and suspected
regional LNs noted on CT, a 4th UGI endoscopy was
done. The pathologic examinations of specimen by
multiple (8 fragments) deep biopsies of these lesions
showed only atypical lymphoid infiltration (prominent
lymphoid aggregates in the lamina propria) without
lymphoepithelial lesion or H. pylori. The immunohis-
tochemistry (IHC) study of those specimens showed
that they were follicular center cells positive for leuko-
cyte common antigen, CD20, CD10 and bcl-6 but
negative for CD3, CD5 and bcl-2. The pathologist
reported that although extranodular marginal zone B
cell lymphoma of mucosa-associated lymphoid tissue
(MALToma) was suspected by histology, IHC study
could not support the impression. Additionally, nested
polymerase chain reaction (PCR) monoclonality studies
for B cell IgH of the biopsy specimen showed smearing
(polyclonal pattern), which did not support the diagnosis
of MALToma. We consulted the surgeon for evaluation
of the necessity of operation. Before operation, a 5th
UGI endoscopy was done in September, which found
a nodular mass with discrete irregular ulcers over the
LCS and posterior wall of the low body and antrum,
which was highly suggestive of gastric lymphoma
(Figure 1). Finally, the pathologic examinations of the
biopsy specimen confirmed the diagnosis of extra-
nodular marginal zone B-cell MALToma negative for
H. pylori infection (Figure 2).
A fasting serum gastrin level of 141 pg/mL (nor-
mal, < 90 pg/mL) was noted from the general blood
routine and biochemical tests, tumor markers such as
α-fetoprotein, carcinogen antigen-199 and carcinoem-
bryonic antigen were within reference limits. Chest
and abdominal X-rays and EKG were also normal.
Finally, radical subtotal gastrectomy with Billroth II
gastrojejunostomy was done in October. The operative
findings included 2 adjacent mass lesions (5×3.5cm and
2×1.8cm) with ulceration over its surface at the LCS of
the antrum and mid-body of the stomach (Figure 3).
The pathologic findings of surgical specimens sug-
gested diffuse large B-cell low-grade lymphoma with
mucosa and submucosa involved. In addition, the
surgical margins of the resected gastric lesion were
negative for tumor involvements, as well as regional
LNs and omentum. No evidence of H. pylori was found
in the specimen examined. Finally, the patient was
discharged 2 weeks after operation, and has received
regular OPD follow-up for 20 months.
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Figure 1. Endoscopic findings of gastric ulcers with irregular mar-
gin and poor distention of the stomach. One submucosal tumor
(2 × 3 cm) was also noted over the lower body with several ulcers
on the surface.
Discussion
The diagnostic criteria for PGL include: (1) no palpable
superficial lymphadenopathy; (2) no obvious enlarge-
ment of mediastinal nodes on chest X-ray; (3) normal
peripheral blood counts and uninvolved bone mar-
row; and (4) absence of liver, spleen, or distant lymph
node involvement.10 In this case, the patient fulfilled
all the above criteria. The majority of PGLs are B cell
non-Hodgkin’s lymphomas. The pathogenesis of H.
pylori infection in PGL begins with an immunologic
response, leading to chronic gastritis with formation
of lymphoid follicles within the stomach. These lym-
phoid follicles resemble nodal tissues found through-
out the body and are composed of reactive T, plasma
and B cells. The B cells are responsible for initiating a
clonal expansion of centrocyte-like cells that form 
the basic histology of MALT lymphoma.11 In some 
H. pylori-negative PGL, association with autoimmune
diseases or infections has been described.7,8,12 There
is a possibility that an unknown bacterium or virus
which behaves like H. pylori may stimulate lymphoid
proliferation in the stomach.13,14 Another possibility
in H. pylori-negative PGL patients is that low bac-
terial counts may escape detection by the currently
available tests. Till now, there has been no consensus
on whether or not these cases should receive triple
therapy.
The main histologic feature of low-grade PGL is
the presence of lymphoepithelial lesions. High-grade
PGL is characterized by malignant infiltrate of large
lymphoid blasts without lymphoepithelial lesions.18
Monoclonality, a positive rate of 67–80%, can be used
to confirm the diagnosis of low-grade PGL cases in
doubt.19 From the patient’s 4th UGI endoscopy, the gas-
tric biopsy specimen was also studied for monoclonality
by nested PCR.
Most cases diagnosed as PGL are elderly persons
who are older than 50 years. Clinically, the challenge
with PGL is to make the diagnosis early enough to
prevent tumor progression from low to high grade.
However, this is not easy as patients may be asympto-
matic or have nonspecific symptoms that overlap with
those of peptic ulcer disease.15 Compatible with these
observations, the patient in this case presented with
nonspecific epigastric pain and abdominal fullness.
Endoscopic findings of PGL include ulceration, poly-
poid mass or diffuse infiltration, which is most com-
monly located over the antrum and low body of the
stomach. Tumors with bulky disease greater than
5 cm are more likely to represent high-grade PGL, 
and the majority of low-grade PGLs behave as diffuse
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Figure 3. The surgical specimen shows 2 adjacent mass lesions
measuring 5 × 3.5 cm and 2 × 1.8 cm with ulceration over its sur-
face located at the lesser curvature side of the mid-body and antrum
of the stomach. Another 2 ulcers (0.8–1 cm) are also found near
them.
Figure 2. (A) Gastric mucosal tissue with sheets of monocytoid lymphocytes in the lamina propria. Destructive infiltration of these 
lymphocytes making lymphoepithelial lesion. (B) These monocytoid lymphocytes in gastric mucosal tissue are positive for CD10 but
negative for the other immunohistochemical stains. No Helicobacter pylori was found in the specimen.
submucosal tumor infiltration.16 Repeat UGI endoscopy
in our case displayed diffuse submucosal tumor with
ulceration on the surface of the antrum, low and high
body of the stomach.
Only 41.9% of cases have a correct histologic diag-
nosis at the 1st endoscopy.17 Submucosal growth of
neoplasm, necrotic material taken during biopsy and
inadequate amount of specimen are conditions that
might render the examination nondiagnostic. Thus,
repeat endoscopies and more aggressive tissue sam-
pling, with multiple and submucosal biopsies of endo-
scopically abnormal and normal mucosa, should be
performed to confirm the diagnosis. This is particularly
important in view of the possible multifocal distribu-
tion of the tumor and potential foci of high-grade
lymphoma.17 Our patient received a total of 5 endo-
scopic examinations with repeat multiple biopsies to
confirm the diagnosis.
The Musshoff modification of the Ann Arbor stag-
ing system is most widely used to evaluate the extent of
PGL by both medical oncologists and gastroenterolo-
gists. With careful examination by repeat UGI endo-
scopies, whole abdominal sonography, abdominal CT
and surgical specimen, our patient was diagnosed to
have low-grade PGL. In this case, UGI series was not
done due to a complete study by repeating UGI endo-
scopies and abdominal CT scan.
Previous studies reported that eradication of H.
pylori accompanied complete regression of low-grade
PGL in 50–100% of cases, with a disease-free survival
time of greater than 6 years post-therapy.20,21 However,
no consensus exists for further treatment after failure
of H. pylori eradication in low-grade PGL and for 
H. pylori-negative cases. Thus, these cases can be treated
with surgery, radiotherapy (RT), or chemotherapy
(C/T). Due to good condition and patient willing-
ness, our case received radical subtotal gastrectomy
with Billroth II for his H. pylori-negative low-grade
PGL. It was reported that radical gastrectomy in
patients with low-grade PGL had 5- and 10-year 
survival rates of 90% and 70%, respectively.21 Actually,
the role of C/T in cases of low-grade PGL was also
discussed in Aviles et al’s series. The relapse-free and
overall survivals were equivalent in both groups with
C/T alone or combined C/T and surgery (75% in
24–28 cases). Cumulative evidence suggested that
surgery might not be necessary for patients with low-
grade PGL with no complications such as bleeding or
perforation.22
Rosin et al reported a 49-year-old woman who
received radical gastrectomy for her low-grade H.
pylori-negative PGL. Postoperatively, she was treated
with RT directed to the tumor bed, with a total dose
of 3 Gy. Despite the absence of H. pylori, antibiotic
triple therapy was administered after the operation.
Repeat endoscopy of that patient 1 year after opera-
tion was negative for tumor recurrence.9 In a series
reported by Taal et al, the 5-year survival rates were
71% (46 cases) and 82% (73 cases), respectively, in
patients with low-grade PGL with RT alone or com-
bined RT and surgery.22–24 However, complete remis-
sion and complication rates were not reported in that
series. Thus, the role of combined RT and surgery
remains unclear.
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